Illumina Rejects Roche $6.7 Billion Takeover Offer

Illumina, the U.S. maker of gene-mapping tools, urged shareholders to reject Roche Holding AG’s increased hostile takeover offer, saying the bid “dramatically undervalues” the company.
The Washington Post